FDA Inspection 1264812 - Tulex Pharmaceuticals Inc. - March 24, 2025

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Record Details

This FDA Inspection record concerns Tulex Pharmaceuticals Inc., with an inspection on March 24, 2025, issued by the New Jersey District Office, covering human drugs.

Company: Tulex Pharmaceuticals Inc.
Inspection Date: March 24, 2025
Product Type: Human Drugs
Office: New Jersey District Office

Open in Dashboard

ID · 3085aa66-b7a0-4815-9e58-5d1875897b55

Violation Codes2

21 CFR 211.160(b)21 CFR 211.192

Full citation text and observation details available on the Dashboard.